Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Aegerion Pharmaceuticals Inc.
Current Parent Company: Amryt Pharma
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $2,700,000
Year: 2017
Date: September 22, 2017
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Violation Description: Aegerion agreed to pay $2.7 million to settle multistate litigation alleging it improperly marketed its drug Juxtapid and thus cause false claims to be submitted to Medicaid programs. This was part of a larger $35 million settlement involving the federal government; see the Violation Tracker entry at (click here)
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.